Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6F7B

Crystal structure of the human Bub1 kinase domain in complex with BAY 1816032

Summary for 6F7B
Entry DOI10.2210/pdb6f7b/pdb
DescriptorMitotic checkpoint serine/threonine-protein kinase BUB1, 2-[3,5-bis(fluoranyl)-4-[[3-[5-methoxy-4-[(3-methoxypyridin-4-yl)amino]pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]ethanol, MAGNESIUM ION, ... (4 entities in total)
Functional Keywordsbub1, kinase inhibitor, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight42042.86
Authors
Primary citationSiemeister, G.,Mengel, A.,Fernandez-Montalvan, A.E.,Bone, W.,Schroder, J.,Zitzmann-Kolbe, S.,Briem, H.,Prechtl, S.,Holton, S.J.,Monning, U.,von Ahsen, O.,Johanssen, S.,Cleve, A.,Putter, V.,Hitchcock, M.,von Nussbaum, F.,Brands, M.,Ziegelbauer, K.,Mumberg, D.
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP InhibitorsIn VitroandIn Vivo.
Clin.Cancer Res., 25:1404-1414, 2019
Cited by
PubMed Abstract: The catalytic function of BUB1 is required for chromosome arm resolution and positioning of the chromosomal passenger complex for resolution of spindle attachment errors and plays only a minor role in spindle assembly checkpoint activation. Here, we present the identification and preclinical pharmacologic profile of the first BUB1 kinase inhibitor with good bioavailability.
PubMed: 30429199
DOI: 10.1158/1078-0432.CCR-18-0628
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon